ASAN vs ASML

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score, limiting distress risk assessment. Despite strong gross margins and accelerating revenue and earnings growth, the company remains deeply unprofitable with negative ROE and ROA, high valuation multiples, and deteriorating insider sentiment. Aggressive insider selling, a bearish technical trend, and a significant disconnect between current price and analyst target further weigh on the outlook. While earnings surprises have been consistently positive, the overall risk profile remains elevated in a high-valuation, low-profitability context.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.